174 related articles for article (PubMed ID: 37144538)
1. Small bowel neuroendocrine tumours - casting the net wide.
Chetcuti Zammit S; Sidhu R
Curr Opin Gastroenterol; 2023 May; 39(3):200-210. PubMed ID: 37144538
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine tumours of the small intestine.
Strosberg J
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):755-73. PubMed ID: 23582917
[TBL] [Abstract][Full Text] [Related]
3. [Small bowel neuroendocrine tumours: to be considered in the differential diagnosis of unexplained abdominal pain and diarrhoea].
Franssen GJH; van Ginhoven TM; Hofland J; Feelders RA; Geilvoet W; van Lanschot JB
Ned Tijdschr Geneeskd; 2020 Jan; 164():. PubMed ID: 32186828
[TBL] [Abstract][Full Text] [Related]
4. Management of Diarrhea in Patients With Carcinoid Syndrome.
Naraev BG; Halland M; Halperin DM; Purvis AJ; OʼDorisio TM; Halfdanarson TR
Pancreas; 2019 Sep; 48(8):961-972. PubMed ID: 31425482
[TBL] [Abstract][Full Text] [Related]
5. Multiple neuroendocrine tumor of the small bowel: a case report and a review of literature.
Kunovský L; Dastych M; Robek O; Svaton R; Vlazny J; Hustý J; Eid M; Poredska K; Kysela P; Kala Z
Vnitr Lek; 2018; 64(10):966-969. PubMed ID: 30590945
[TBL] [Abstract][Full Text] [Related]
6. Gastroenteropancreatic Neuroendocrine Tumors.
Cives M; Strosberg JR
CA Cancer J Clin; 2018 Nov; 68(6):471-487. PubMed ID: 30295930
[TBL] [Abstract][Full Text] [Related]
7. Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials.
Cives M; Soares HP; Strosberg J
Curr Opin Oncol; 2016 Jul; 28(4):359-66. PubMed ID: 27138571
[TBL] [Abstract][Full Text] [Related]
8. Management of Small Bowel Neuroendocrine Tumors.
Scott AT; Howe JR
J Oncol Pract; 2018 Aug; 14(8):471-482. PubMed ID: 30096273
[TBL] [Abstract][Full Text] [Related]
9. Management of Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEPNETs): A Review.
Pasricha G; Padhi P; Daboul N; Monga DK
Clin Ther; 2017 Nov; 39(11):2146-2157. PubMed ID: 29173655
[TBL] [Abstract][Full Text] [Related]
10. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Phan AT; Kunz PL; Reidy-Lagunes DL
Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
Kaltsas GA; Papadogias D; Makras P; Grossman AB
Endocr Relat Cancer; 2005 Dec; 12(4):683-99. PubMed ID: 16322317
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment.
Oberg K
Ann Oncol; 1999; 10 Suppl 2():S3-8. PubMed ID: 10399026
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: A systematic review.
Khan MS; Walter T; Buchanan-Hughes A; Worthington E; Keeber L; Feuilly M; Grande E
World J Gastroenterol; 2020 Aug; 26(30):4537-4556. PubMed ID: 32874063
[TBL] [Abstract][Full Text] [Related]
14. [Management of patients with neuroendocrine tumors of the esophagus, stomach, and duodenum].
Shimizu N; Kaminishi M
Nihon Geka Gakkai Zasshi; 2008 May; 109(3):147-51. PubMed ID: 18536318
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapy: New Radiolabeled Somatostatin Analogs to Treat Gastroenteropancreatic Neuroendocrine Tumors.
Boucher JE; Sommers R
Clin J Oncol Nurs; 2018 Oct; 22(5):565-568. PubMed ID: 30239510
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.
Stueven AK; Kayser A; Wetz C; Amthauer H; Wree A; Tacke F; Wiedenmann B; Roderburg C; Jann H
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234481
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of neuroendocrine tumours.
Cuthbertson DJ; Shankland R; Srirajaskanthan R
Clin Med (Lond); 2023 Mar; 23(2):119-124. PubMed ID: 36958842
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
Bednarczuk T; Bolanowski M; Zemczak A; Bałdys-Waligórska A; Blicharz-Dorniak J; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nowakowska-Duława E; Pałucki J; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Strzelczyk J; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zgliczyński W; Kos-Kudła B
Endokrynol Pol; 2017; 68(2):223-236. PubMed ID: 28540974
[TBL] [Abstract][Full Text] [Related]
19. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.
Sundin A
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):803-18. PubMed ID: 23582920
[TBL] [Abstract][Full Text] [Related]
20. Peptide receptor therapies in neuroendocrine tumors.
Bodei L; Ferone D; Grana CM; Cremonesi M; Signore A; Dierckx RA; Paganelli G
J Endocrinol Invest; 2009 Apr; 32(4):360-9. PubMed ID: 19636207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]